Acquiring Company
G2
Acquired Company
Lophos Pharma
Description
Greenridez 2.0 Acquisitions Corp. (the "Company") is pleased to announce that it has completed its acquisition of psychedelic research company Lophos Pharma (“Lophos”).
Quick answer
G2 is acquiring Lophos Pharma, announced January 21, 2022.
- How much did G2 pay for Lophos Pharma?
- The deal value was not disclosed.
- Who are the decision-makers at G2?
- Fundz holds 1 contact at G2. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Data And Analytics and Science And Engineering
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Intellia Therapeutics Announces Acquisition Of Rewrite Therapeutics (February 3, 2022)
- Element Biosciences Closes Acquisition Of Loop Genomics (February 8, 2022)
- Glooko Acquires Germany-Based Xbird, A Medical Ai Company (January 31, 2022)
- Medtronic To Acquire Affera (January 10, 2022)
- Trella Health Acquires Playmaker Health (January 4, 2022)
- Aetion Acquires Synthetic Data Trailblazer Replica Analytics (January 4, 2022)
Who to call at G2, and when
When G2 changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day G2 raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at G2, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at G2. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment G2 makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Lophos Pharma?
Lophos Pharma was acquired by G2. The deal was reported on January 21, 2022. G2 is privately held.
When did G2 acquire Lophos Pharma?
G2's acquisition of Lophos Pharma was reported on January 21, 2022. Greenridez 2.0 Acquisitions Corp. (the "Company") is pleased to announce that it has completed its acquisition of psychedelic research company Lophos Pharma (“Lophos”). Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Lophos Pharma do?
Lophos is a biosciences company that specializes in Peyote research, cultivation, preservation, and drug development. We develop novel therapies and natural health treatments that aim to restore and improve the quality of life for patients. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.